SynCore Biotechnology Co.,Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 20.2 million compared to TWD 15.86 million a year ago. Net loss was TWD 38.17 million compared to TWD 188.67 million a year ago.

Basic loss per share from continuing operations was TWD 1.19 compared to TWD 6.14 a year ago.